Genetic Engineering & Biotechnology details trends in animal and humanized models available at Taconic:
"Revamped Allograft and Innovative Xenograft Models Can Reduce the Risks of Late-Stage Clinical Trials and Increase the Odds of Translational Success - Precision medicine is all about the two T's—targets and treatments—targets that emerge from analyses of patient-specific information, and treatments that hit these targets. Both T's, however, pose difficulties. All too often, insights and drug candidates originating in precision medicine fail to translate into clinical practice."
Read the complete article at: Genengnews.com
"Revamped Allograft and Innovative Xenograft Models Can Reduce the Risks of Late-Stage Clinical Trials and Increase the Odds of Translational Success - Precision medicine is all about the two T's—targets and treatments—targets that emerge from analyses of patient-specific information, and treatments that hit these targets. Both T's, however, pose difficulties. All too often, insights and drug candidates originating in precision medicine fail to translate into clinical practice."